日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial

托瑞普利单抗联合铂类化疗放疗治疗局部晚期宫颈癌患者：一项开放标签、单臂 II 期试验

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09866-w
Chen, Jie; Li, Chen; Cao, Yuanjie; Zhu, Li; Zhang, Bailin; You, Jinqiang; Hou, Hailing; Wang, Jing; Yuan, Zhiyong
宫颈癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc

NS1结合蛋白通过转录抑制c-Myc来增强食管鳞状细胞癌的放射敏感性。

期刊:Cancer Communications
影响因子:24.9
doi:10.1186/s40880-018-0307-y
Wang, Yuwen; Cheng, Jingjing; Xie, Dan; Ding, Xiaofeng; Hou, Hailing; Chen, Xi; Er, Puchun; Zhang, Furong; Zhao, Lujun; Yuan, Zhiyong; Pang, Qingsong; Wang, Ping; Qian, Dong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer

更正：卤夫吉酮抑制肺癌放射治疗诱导的上皮-间质转化

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.25958
Chen, Yang; Liu, Weishuai; Wang, Peng; Hou, Hailing; Liu, Ningbo; Gong, Linlin; Wang, Youyou; Ji, Kai; Zhao, Lujun; Wang, Ping
肺癌
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.

卤夫酮可抑制肺癌放射治疗诱导的上皮-间质转化

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.11217
Chen Yang, Liu Weishuai, Wang Peng, Hou Hailing, Liu Ningbo, Gong Linlin, Wang Youyou, Ji Kai, Zhao Lujun, Wang Ping
肿瘤
肺癌
发表日期：2016
文献求助 收藏

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy

对接受厄洛替尼联合胸部放疗治疗的非小细胞肺癌患者发生放射性肺炎的危险因素进行初步分析

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S62707
Zhuang, Hongqing; Hou, Hailing; Yuan, Zhiyong; Wang, Jun; Pang, Qingsong; Zhao, Lujun; Wang, Ping
肺炎
肺癌
肿瘤
肿瘤免疫
细胞生物学
发表日期：2014
文献求助 收藏